Screening and diagnostic strategies for active pulmonary tuberculosis among people in prison in Malaysia: a prospective diagnostic study

马来西亚监狱人群活动性肺结核筛查和诊断策略:一项前瞻性诊断研究

阅读:1

Abstract

BACKGROUND: The World Health Organization (WHO) recommends tuberculosis (TB) screening in prisons but data on specific strategies are lacking. METHODS: Men sequentially entering Kajang Prison, Malaysia's largest prison, underwent standardized WHO symptom screening (SS), chest X-ray (CXR), and c-reactive protein (CRP ≥5 mg/L) screening tests while acid-fast bacilli (AFB) smears and Xpert were diagnostic tests. The reference standard was culture. We defined three screening strategies and compared their sensitivity, specificity, positive predictive value, negative predictive value, receiver operator curves, and area under the curve (AUC). FINDINGS: We enrolled 588 people in prison, mean age 43 (range: 21-68) years, 60 (10.2%) with HIV, 493 (83.8%) with opioid use disorder, and 265 (45.1%) with HCV. Among these, 34 (5.8%) were diagnosed with culture-positive active pulmonary TB (PTB). For screening, the sensitivity of SS, CRP ≥5 mg/L, and CXR demonstrating PTB was 38.2% (95% CI 22.2-56.4), 47.1% (95% CI 29.8-64.9), and 91.2% (95% CI 76.3-98.1). Among people without HIV, "SS-CXR" had the highest AUC (74.7% [95% CI 68.6-80.7]). For people with HIV, however, "SS-CRP" had the highest AUC (85.5% [95% CI 79.4-91.5]). For diagnosis, Xpert had a higher sensitivity (82.4% [95% CI 65.5-93.2] and specificity (95.5% [95% CI 93.4-97.1]) than AFB smear. Compared to "SS-Xpert", both "SS-CXR-Xpert" and "SS-CRP-Xpert" had a significantly higher AUC in people without HIV (84.2% p < 0.0001 and 72.9% p = 0.023, respectively) and people with HIV (87.3% p = 0.022 and 88.2% p = 0.018, respectively). INTERPRETATION: Among people in prison, adding CXR or CRP to symptom screen was more effective than symptom screen alone. In addition to symptom screen, CRP performed better than CXR among people with HIV while CXR was more valuable than CRP among people without HIV. FUNDING: U.S. National Institute on Drug Abuse.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。